نتایج جستجو برای: glioblastoma

تعداد نتایج: 25259  

Journal: :iranian journal of pathology 2015
noushin afshar moghaddam parvin mahsuni diana taheri

background and objectives: angiogenesis is essential for growth and metastasis of solid malignancies. tumor vessel count and expression of vascular endothelial growth factor (vegf), a potent angiogenic factor, have been associated with prognosis. this study was designed to assess vessels density by using cd31 and cd105 (endoglin) and their correlation with expression of vegf and proliferative i...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2013
Haitao Ji Zhimin Lu

Glioblastoma is the most prevalent and malignant primary brain tumor in adults, and its response to current therapies is limited. Protein kinase CK2 is overexpressed in glioblastoma and regulates glioblastoma cell survival, proliferation, and migration and brain tumorigenesis. Targeting CK2 for glioblastoma treatment may benefit patients with glioblastoma.

2011

Sample Tumor Type C.1 (low/high) C.2 (anapl/non-anapl) C.3 (gliob/non-gliob) C.4 (glios/non-glios) T19 Oligodendroglioma l n ngb ngs T21 Anaplastic mixed glioma l a ngb ngs T24 Anaplastic mixed glioma l a ngb ngs T18 Glioblastoma/Gliosarcoma h n ngb/gb ngs/gs T20 Glioblastoma h n gb ngs T22 Glioblastoma h n gb ngs T23 Glioblastoma h n gb ngs T25 Glioblastoma h n gb ngs T26 Glioblastoma h n gb n...

Journal: :Oncology reports 2016
Hao Li Yaodong Liu Yumin Jiao Anchen Guo Xiaoxue Xu Xianjun Qu Shuo Wang Jizong Zhao Ye Li Yong Cao

Glioblastoma-initiating cells play crucial roles in the origin, growth, and recurrence of glioblastoma multiforme. The elimination of glioblastoma-initiating cells is believed to be a key strategy for achieving long-term survival of glioblastoma patients due to the highly resistant property of glioblastoma-initiating cells to temozolomide. Resveratrol, a naturally occurring polyphenol, has been...

Journal: :acta medica iranica 0
reza raoofian department of medical genetics, faculty of medicine, tehran university of medical sciences, tehran, iran. mohammad reza noori-daloii department of medical genetics, faculty of medicine, tehran university of medical sciences, tehran, iran. samira saee-rad department of medical genetics, faculty of medicine, tehran university of medical sciences, tehran, iran. mohammad hossein modarresi department of medical genetics, faculty of medicine, tehran university of medical sciences, tehran, iran. seyed hamid ghaffari hematology, oncology and bmt research center, shariati hospital, tehran university of medical sciences, tehran, iran. majid mojarrad department of medical genetics, school of medicine, mashhad university of medical sciences, mashhad, iran.

glioblastoma is the most common and the most lethal primary brain cancer. this malignancy is highly locally invasive, rarely metastatic and resistant to current therapies. little is known about the distinct molecular biology of glioblastoma multiforme (gbm) in terms of initiation and progression. so far, several molecular mechanisms have been suggested to implicate in gbm development. homeodoma...

Journal: :iranian journal of immunology 0
alireza haghparast laboratory of immunoregulation, department of pathobiology, faculty of veterinary medicine maryam heidari kharaji laboratory of immunoregulation, department of pathobiology, faculty of veterinary medicine amir mohammad malvandi laboratory of immunoregulation, department of pathobiology, faculty of veterinary medicine

background: pattern recognition receptors (prrs) are the main sensors of pathogen and danger signals in innate immunity of which toll like receptors (tlrs) are the most studied ones. the contribution of prrs in cerebral inflammation induced by microbial infection, tissue damage and cancer has not extensively been addressed so far. glioma is the most common tumor of the central nervous system an...

Journal: :iranian journal of radiation research 0
f. amouzegar hashemi department of radiation oncology, cancer institute, imam khomeini hospital, keshavarz blvd, tehran, iran a. maddah safaei department of radiation oncology, cancer institute, imam khomeini hospital, keshavarz blvd, tehran, iran e. esmati department of radiation oncology, cancer institute, imam khomeini hospital, keshavarz blvd, tehran, iran

radiation induced sarcoma is a rare but recognized complication of radiotherapy and is associated with poor prognosis, frequently occurs 5 years after completion of treatment. we report radiation-induced sarcoma in a 42 years old male, involving the left parietooccipital scalp region following treatment of brain tumor with craniotomy and post-operative radiation with 60co machine. diagnosis of ...

2012
Salvatore J. Coniglio Eliseo Eugenin Kostantin Dobrenis E. Richard Stanley Brian L. West Marc H. Symons Jeffrey E. Segall

Glioblastoma multiforme is a deadly cancer whose current treatment options are limited. The ability of glioblastoma tumor cells to infiltrate the surrounding brain parenchyma critically limits the effectiveness of current treatments. We investigated how microglia, the resident macrophages of the brain, stimulate glioblastoma cell invasion. We first examined the ability of normal microglia from ...

Journal: :Molecular medicine 2012
Salvatore J Coniglio Eliseo Eugenin Kostantin Dobrenis E Richard Stanley Brian L West Marc H Symons Jeffrey E Segall

Glioblastoma multiforme is a deadly cancer for which current treatment options are limited. The ability of glioblastoma tumor cells to infiltrate the surrounding brain parenchyma critically limits the effectiveness of current treatments. We investigated how microglia, the resident macrophages of the brain, stimulate glioblastoma cell invasion. We first examined the ability of normal microglia f...

2017
Ninh B. Doan Hisham Alhajala Mona M. Al-Gizawiy Wade M. Mueller Scott D. Rand Jennifer M. Connelly Elizabeth J. Cochran Christopher R. Chitambar Paul Clark John Kuo Kathleen M. Schmainda Shama P. Mirza

Glioblastoma remains the most common, malignant primary cancer of the central nervous system with a low life expectancy and an overall survival of less than 1.5 years. The treatment options are limited and there is no cure. Moreover, almost all patients develop recurrent tumors, which typically are more aggressive. Therapeutically resistant glioblastoma or glioblastoma stem-like cells (GSCs) ar...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید